🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
26.69
+0.28 (1.06%)
Nov 18, 2026, 4:00 PM EST - Market closed

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $11.26M in the quarter ending September 30, 2026, with 5.86% growth. This brings the company's total for the last twelve months to $28.21M, down -86.28% year-over-year. In the year 2025, Stoke Therapeutics had annual revenue of $184.42M with 404.50% growth. That makes Stoke Therapeutics the 31,793rd largest company in the world by revenue and 4,179th in the United States.

Revenue (ttm)
$28.21M
Revenue Growth
-86.28%
P/S Ratio
62.88
Revenue / Employee
$165,941
Employees
170
Market Cap
1.75B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025184.42M147.87M404.50%
Dec 31, 202436.56M27.78M316.34%
Dec 31, 20238.78M-3.63M-29.22%
Dec 31, 202212.41M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.